6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Edition of Euro-Global Conference on Biotechnology and Bioengineering — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
6th Edition of Euro-Global Conference on Biotechnology and Bioengineering (ECBB 2026)
The 6th Edition of Euro-Global Conference on Biotechnology and Bioengineering (ECBB 2026) is a distinguished hybrid event that will take place from September 28-30, 2026, in London, UK, and virtually. Hosted at Delta Hotels Heathrow Windsor, located at Ditton Rd, Langley, Slough SL3 8PT, United Kingdom, this conference is a premier gathering for professionals in the biotechnology and bioengineering fields.
Event Overview
ECBB 2026 is themed "Advancing Biotechnology & Bioengineering: From Concepts to Impact" and is designed to bring together a dynamic community of academic leaders, pioneering researchers, industry professionals, entrepreneurs, and policy influencers. This event provides a platform for exchanging knowledge, fostering innovation, and creating opportunities for meaningful collaborations that will shape the future of biotechnology and bioengineering.
Event Details
- Dates: September 28-30, 2026
- Venue: Delta Hotels Heathrow Windsor, Ditton Rd, Langley, Slough SL3 8PT, United Kingdom
- Location: London, UK (Hybrid event - in person and virtual attendance options)
- Contact: Phone: +1 (702) 988-2320, WhatsApp: +1 (640) 666-9566, Email: [email protected]
Scientific Sessions
ECBB 2026 features a comprehensive range of scientific sessions, including:
- Molecular Biotechnology & Cellular Biotechnology
- Biochemical Engineering & Metabolic Engineering
- Agricultural & Plant Biotechnology
- Nano-Biotechnology & Biomaterials
- Stem Cell & Regenerative Medicine
- Tissue Engineering & 3D Bioprinting
- Biosensors, Bioimaging & Bioinstrumentation
- Bioinformatics, Computational Biology & AI in Biotech
- Gene Therapy & RNA Therapeutics
- Vaccine Development & Immunotechnology
- Microbial Biotechnology & Synthetic Microbiology
- Quantum Biology & Emerging Biotech Trends
- Proteomics and Metabolomics
- Genomics and Genetic Engineering
Target Audience
ECBB 2026 attracts a wide range of attendees, including:
- Academic Leaders
- Pioneering Researchers
- Industry Professionals
- Entrepreneurs
- Policy Influencers
Event Highlights
The conference offers a variety of engaging activities, such as:
- Keynote Lectures
- Interactive Sessions
- Oral and Poster Presentations
- Workshops
Registration and Abstract Submission
Those interested in attending or presenting at ECBB 2026 can submit their abstracts and register for the event. Important dates include:
- Abstract Submission Deadline: June 27, 2026
- Early Bird Registration Deadline: June 30, 2026
Get Updates
Stay informed about ECBB 2026 by signing up for updates. Provide your email address and name to receive the latest news and information about the conference.
About the Organizer
ECBB 2026 is organized by Magnus Group, a renowned organizer of scientific conferences and events. The group is committed to providing a platform for the exchange of ideas and collaboration among professionals in various scientific fields.
Data sheet
6th Edition of Euro-Global Conference on Biotechnology and Bioengineering – Event Attendee & Buyer Profile Analysis
Event date: September 28–30, 2026
Location: London, United Kingdom | Venue: Delta Hotels Heathrow Windsor
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 6th Edition of Euro-Global Conference on Biotechnology and Bioengineering (ECBB 2026) |
| Event Date | September 28–30, 2026 |
| Event Status | Upcoming |
| Venue | Delta Hotels Heathrow Windsor |
| City | London (official event city listing). Venue address is Ditton Rd, Langley, Slough SL3 8PT. |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Magnus Group |
| Official Event Website | biotechnology-conferences.magnusgroup.org |
| Event Type | Hybrid scientific conference and networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for headcount; high for event identity, date, venue, format, and thematic focus based on the official event page. |
| Main Purpose of Event | To convene biotechnology and bioengineering stakeholders for research exchange, scientific presentation, industry dialogue, innovation visibility, collaboration building, and commercialization-oriented networking. |
About the Event
The 6th Edition of Euro-Global Conference on Biotechnology and Bioengineering (ECBB 2026) is an official hybrid conference scheduled for September 28–30, 2026 in London, United Kingdom, with virtual participation also available. According to the organizer, the conference theme is “Advancing Biotechnology & Bioengineering: From Concepts to Impact,” and the agenda spans molecular biotechnology, biochemical engineering, regenerative medicine, biomaterials, bioinformatics, AI in biotech, gene therapy, vaccine development, microbial biotechnology, genomics, and related innovation areas.
From a commercial and lead-generation perspective, ECBB 2026 is best viewed as a high-intent scientific and innovation networking environment rather than a mass trade exhibition. The strongest attendee-value segments are likely to include R&D leaders, translational research teams, biotech founders, instrument and platform evaluators, computational biology specialists, clinical innovation stakeholders, and partnership-focused business development professionals. It is relevant for suppliers selling research tools, lab technologies, software platforms, biologics-enabling services, contract research support, data platforms, instrumentation, advanced materials, and collaboration or licensing solutions.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Biotechnology R&D leaders | Biotech companies, platform developers, therapeutics innovators | Influence over lab tools, assay systems, data platforms, CRO/CDMO selection, and research partnerships | High relevance for scientific equipment, consumables, software, and outsourced R&D services |
| Academic researchers and principal investigators | Universities, research institutes, translational labs | Evaluate research platforms, instrumentation, grants collaboration, and publication-support tools | Strong for scientific product adoption, trial usage, and collaboration pipeline development |
| Bioengineering and process development teams | Bioprocessing firms, manufacturing science teams, engineering groups | Influence process optimization, scaling tools, biomaterials selection, and production technologies | Relevant for equipment vendors, automation providers, bioprocess analytics, and engineering services |
| Computational biology and bioinformatics specialists | Bioinformatics groups, omics analytics teams, AI-driven biotech programs | Assess data infrastructure, modeling software, pipelines, cloud environments, and AI tools | High fit for SaaS, data management, computational platforms, and analytics partners |
| Clinical and regenerative medicine innovators | Hospitals, clinical research units, stem cell and tissue engineering programs | Influence lab methods, translational collaborations, imaging tools, and cell-therapy enabling technologies | Relevant for cell culture systems, imaging, QC, data capture, and therapeutic development partners |
| Entrepreneurs and startup founders | Early-stage biotech ventures, spinouts, innovation-led startups | Can buy pilot services, shared lab tools, consulting, and commercialization support | Good for early-stage prospecting and partnership outreach |
| Business development and alliance professionals | Biotech companies, pharma partners, innovation intermediaries | Shape licensing, co-development, research partnerships, and service-provider selection | Important for strategic outreach and deal origination |
| Policy influencers and scientific ecosystem stakeholders | Public bodies, associations, innovation clusters, grant-linked organizations | Less direct purchasing, but strong influence on collaboration programs and research ecosystem access | Useful for partnerships, market visibility, and ecosystem positioning |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | London | High | Official event city is London; this supports access to biotech investors, universities, hospitals, and life sciences companies. |
| Venue catchment | Heathrow / Slough / West London corridor | Medium to High | The venue address is in Langley, Slough, near Heathrow, which is favorable for international arrivals and regional business access. |
| Host region | England | High | Likely to draw attendees from life sciences clusters across England, especially London, Oxford, Cambridge, and the wider South East. |
| Nearby business hubs | London–Oxford–Cambridge triangle and South East research hubs | High | Strong match for biotech, pharma, computational biology, and university-linked innovation networks. |
| National reach | United Kingdom-wide scientific and commercial audience | Medium to High | Relevant for UK universities, biotech firms, hospitals, and public research stakeholders. |
| International reach | Europe and wider global hybrid audience | High | The event is branded “Euro-Global” and explicitly offers virtual attendance from anywhere, supporting broader international participation. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Hybrid delivery, international positioning, and broad biotechnology topic coverage indicate a global scientific and industry audience rather than a local-only meeting. |
| National | Secondary practical reach | The UK location makes the event especially relevant for domestic life sciences networks and London-area meetings. |
4. Sample Buyer Companies and Websites
The supplied official event source confirms the event identity, venue, dates, hybrid format, theme, and scientific sessions, but it does not publish a current-year attendee list, sponsor directory, exhibitor list, or speaker-organization roster in the provided text. To avoid unsupported claims, no company is stated below as attending unless confirmed in the supplied official material.
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No current-year buyer organizations publicly confirmed in the supplied official event text | Not publicly disclosed | Organizer has not provided a verifiable current-year attendee, sponsor, exhibitor, or speaker-organization list in the source text supplied for this report. | — | — | Confirmed current-year disclosure unavailable |
Practical interpretation: this event may still be useful for biotech prospecting, but at present it is better suited to domain-based Apollo targeting and speaker/abstract/agenda monitoring than to confirmed attendee-list building.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Scientific Officer | R&D / Scientific Leadership | C-Level | Owns strategic research direction and often influences platform, partnership, and technology decisions. |
| 2 | VP Research & Development | R&D | VP | Key for evaluating innovation partners, tools, assay platforms, and service providers. |
| 3 | Director of Bioinformatics | Data Science / Computational Biology | Director | Important for AI, analytics, data pipelines, genomic workflows, and software platform adoption. |
| 4 | Head of Translational Research | Translational Science | Director / Head | Bridges discovery, preclinical, and clinical needs; often evaluates enabling technologies and partnerships. |
| 5 | Principal Investigator | Academic Research | Senior Individual Contributor / Faculty | High influence in academic purchasing, collaboration, and method selection. |
| 6 | Laboratory Director | Laboratory Operations | Director | Relevant for instrumentation, workflow systems, compliance tools, and consumables. |
| 7 | Process Development Director | Bioprocess / Manufacturing Science | Director | Strong buyer for engineering, analytics, automation, and scale-up solutions. |
| 8 | Business Development Director | Partnerships / Commercial | Director | Critical for licensing, service partnerships, co-development, and strategic outreach. |
| 9 | Innovation Program Manager | Innovation / Strategy | Manager | Useful contact for pilots, consortium work, and early technology scanning. |
| 10 | Procurement Manager, Scientific Supplies | Procurement | Manager | Relevant where the offer involves equipment, reagents, instruments, software licensing, or lab service contracts. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Direct thematic fit with the conference title and agenda. | Research platforms, assays, software, services, partnerships |
| 2 | Pharmaceuticals | Relevant for translational science, therapeutics, vaccines, and biologics-linked teams. | Drug discovery, translational research, alliance management |
| 3 | Research | Matches independent institutes, labs, and public or private research entities. | Instruments, reagents, analytics, collaboration tools |
| 4 | Higher Education | Academic leaders and researchers are explicitly part of the target audience. | Lab procurement, research collaboration, educational partnerships |
| 5 | Medical Devices | Relevant to biosensors, bioimaging, instrumentation, and bioengineering devices. | Imaging, diagnostics, sensor technologies, device collaborations |
| 6 | Hospital & Health Care | Supports regenerative medicine, clinical translation, and applied healthcare biotech use cases. | Clinical research tools, translational partnerships, imaging and analytics |
| 7 | Information Technology & Services | Useful for biotech data infrastructure and digital R&D enablement. | Data management, cloud infrastructure, integration services |
| 8 | Computer Software | Fits bioinformatics, computational biology, AI, and modeling tools. | Scientific SaaS, genomic analytics, workflow platforms |
| 9 | Nanotechnology | Aligned with nano-biotechnology and biomaterials sessions. | Materials innovation, delivery systems, sensor platforms |
| 10 | Government Administration | Potentially relevant through policy influencers and public research stakeholders. | Public research programs, innovation policy, grant ecosystems |
| 11 | Venture Capital & Private Equity | Useful where startup and innovation scouting are part of event networking. | Investment sourcing, portfolio support, biotech partnerships |
| 12 | Management Consulting | Relevant for scientific strategy, commercialization advisory, and innovation services. | Commercialization strategy, partner search, market intelligence |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official event page text supplied | No numeric attendee count was disclosed in the provided official source. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official event page text supplied | Conference appears content-led rather than exhibitor-led in the provided source. |
| Buyer count | Not publicly confirmed | Unconfirmed | Official event page text supplied | No formal hosted-buyer or procurement-buyer program disclosed. |
| Speaker count | Not publicly confirmed in supplied text | Unconfirmed | Official event page text supplied | Speakers menu exists, but no count or organization list was included in the supplied content. |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official event page text supplied | No sponsor list was visible in the supplied text. |
| Historical attendance | Not verified from supplied source | Historical data unavailable | No prior-year metrics in supplied text | Prior-year attendance evidence was not included in the provided official excerpt. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Molecular and cellular biotechnology | Assays, reagents, analysis tools, workflow improvement | Method comparisons, pilot programs, technical demos | Lab instruments, consumables, analytics platforms |
| Biochemical and metabolic engineering | Process optimization, scale-up support, engineering analytics | Technical workshops and process-focused case studies | Bioprocess tools, automation, monitoring systems |
| Stem cell and regenerative medicine | Cell handling, quality control, translational collaboration | Clinical-science networking and partner search | Cell culture systems, imaging, biomaterials, QC software |
| Tissue engineering and 3D bioprinting | Materials, design systems, prototyping workflows | Innovation showcase and co-development discussion | Biomaterials, printers, modeling software, engineering support |
| Biosensors, bioimaging and bioinstrumentation | Device performance, imaging quality, integration capability | Live demos, validation discussions, pilot deployments | Sensors, imaging systems, diagnostics, instrumentation |
| Bioinformatics, computational biology and AI in biotech | Data processing, model development, workflow automation | Software-led discovery calls and architecture discussions | SaaS, analytics engines, cloud, AI/ML tools, data management |
| Gene therapy and RNA therapeutics | Translational support, development platforms, analytics | Partner introductions and scientific solution mapping | Development services, delivery technologies, assay tools |
| Vaccine development and immunotechnology | Research acceleration, validation, manufacturing support | Strategic BD meetings and technical qualification discussions | Assays, bioprocess tools, software, contract research support |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong for biotech, life sciences, scientific software, instrumentation, and R&D services. |
| Decision-maker availability | Medium to High | Conference positioning suggests access to senior scientific, innovation, and partnership stakeholders, though direct procurement presence is not clearly disclosed. |
| Data collection potential | Medium | Good if speaker lists, abstract presenters, or program participants become public; currently limited by lack of disclosed attendee directory. |
| Apollo targeting potential | Very High | The event themes map well to clear industry, role, and keyword filters in Apollo. |
| Geographic targeting potential | High | London, the UK, and major European biotech corridors provide strong geographic clustering. |
| Best outreach approach | High-fit scientific-value outreach | Position around research acceleration, workflow gains, translational support, or collaboration value rather than generic sales messaging. |
| Overall lead quality | High | High-value niche audience, especially for advanced biotech offerings, though not ideal for mass attendee list extraction at the current disclosure level. |
| Best use case | Targeted prospecting and partnership outreach | Best used for selective outreach to scientific, R&D, computational, and innovation stakeholders. |
| Limitations / risks | Medium | Current public source does not confirm attendance numbers or company-level participation; attendee list sales suitability is limited until more official participant data is published. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Research; Higher Education; Medical Devices; Hospital & Health Care; Information Technology & Services; Computer Software; Nanotechnology; Government Administration; Venture Capital & Private Equity; Management Consulting | Build a high-fit buyer universe aligned to event themes. |
| Departments | Research; Engineering; Information Technology; Operations; Business Development; Product; Procurement | Capture both scientific and commercial decision-makers. |
| Seniority | Owner; Founder; C-Suite; VP; Director; Head; Manager | Focus on budget holders and strategic evaluators. |
| Job titles | Chief Scientific Officer; VP Research & Development; Director of Bioinformatics; Head of Translational Research; Principal Investigator; Laboratory Director; Process Development Director; Business Development Director; Head of Innovation; Scientific Program Manager; Procurement Manager | Mirror the roles most likely to engage with ECBB themes and solution categories. |
| Geography | United Kingdom; London; Oxford; Cambridge; Slough; England; Ireland; Germany; Switzerland; Netherlands; Belgium; France; Nordics; broader Europe; selected North America biotech hubs | Reflect likely physical and virtual participation corridors. |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000 | Covers startups, scale-ups, and mid-market to enterprise science organizations. |
| Keywords | biotechnology, bioengineering, molecular biology, cellular biology, metabolic engineering, stem cell, regenerative medicine, tissue engineering, 3D bioprinting, biosensors, bioimaging, bioinstrumentation, bioinformatics, computational biology, AI in biotech, gene therapy, RNA therapeutics, vaccine development, immunotechnology, synthetic microbiology, proteomics, metabolomics, genomics, genetic engineering | Aligns directly with official scientific sessions. |
| Technologies, if relevant | Cloud data platforms, AI/ML analytics, LIMS, imaging systems, lab automation, genomics workflows | Useful for software, data, and instrumentation suppliers. |
| Revenue range, if relevant | $1M–$10M; $10M–$50M; $50M–$250M; $250M+ | Segment outreach between early-stage, growth-stage, and established buyers. |
| Company type | Private company; Public company; University / research institution; Hospital / clinical research organization | Improves precision based on go-to-market model. |
| Funding / public company filters, if relevant | Recently funded biotech startups; publicly listed life sciences firms; venture-backed research platforms | Useful where the client sells growth-enabling tools or strategic services. |
Suggested Apollo Search Logic: ("biotechnology" OR "bioengineering" OR "bioinformatics" OR "computational biology" OR "genomics" OR "gene therapy" OR "RNA therapeutics" OR "vaccine development" OR "regenerative medicine" OR "3D bioprinting" OR "biosensors") AND (CSO OR "VP R&D" OR "Director of Bioinformatics" OR "Head of Translational Research" OR "Laboratory Director" OR "Business Development Director") AND geography in UK/Europe biotech hubs.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ECBB 2026 Official Event Website | Official event website | Verified event name, hybrid format, dates, official event city, venue name, venue address, organizer branding, theme, and scientific sessions. | High |
| ECBB 2026 Official Page Sections: About, Program, Venue, Speakers, Scientific Sessions | Official page navigation / content sections | Confirmed that the event is content-led and that no attendee count, sponsor count, or company-level participant roster was visible in the supplied official text excerpt. | High for what is shown; limited for undisclosed metrics |
| User-supplied official website text excerpt | Primary-source extract | Used as the primary source of truth for date, city, venue, country, organizer positioning, and agenda themes in this report. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Edition of Euro-Global Conference on Biotechnology and Bioengineering — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds